Tune into this webinar to learn how the Cell and Gene Therapy Catapult can provide you with essential non-clinical and health economic support to help progress your ATMP from the pre-clinical stage through to first in human clinical trials.
Watch the Webinar
Please provide your details to gain access.
In this webinar, the Cell and Gene Therapy Catapult’s Non-clinical and Health Economics and Market Access teams illustrate how a non-clinical programme is designed, and how to incorporate health economics into the clinical development plan at an early-stage to optimise the adoption potential of an advanced therapy. This is part one of a series of two webinars highlighting key considerations for the successful translation of advanced therapies.
You will gain an in-depth understanding of how non-clinical studies provide scientific insight into potential efficacy and safety of an advanced therapy, and why they are critical to assess the risk:benefit relationship with clinical relevance. The importance of incorporating commercial considerations into the early-stage clinical strategy will also be highlighted for its value in helping to overcome the high adoption barriers faced by advanced therapies when they come to market.
Who should watch: Therapy developers who are on the clinical development path and looking for support to increase the adoption potential of their ATMP .